June 20, 2017 / 6:40 AM / a month ago

BRIEF-Cerenis Therapeutics secures EUR 0.75 mln loan from Bpifrance

1 Min Read

June 20 (Reuters) - CERENIS THERAPEUTICS HOLDING SA

* CERENIS THERAPEUTICS: BPIFRANCE SUPPORTS THE CLINICAL DEVELOPMENT OF CER-209 IN NAFLD /NASH WITH A €0.75 MILLION PAYMENT FOR INNOVATION

* ‍NON-DILUTIVE FINANCING OF EUR 0.75 MILLION IN FORM OF AN INTEREST-FREE INNOVATION LOAN​

* Available Cash at End-May 2017: Eur 21.5 Million

* ‍KEY MILESTONE REACHED IN CLINICAL DEVELOPMENT OF CER-209​

* ‍THIS AMOUNT CORRESPONDS TO FINANCING OF SECOND TRANCHE OF A BPIFRANCE'S INNOVATION AID​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below